Author
The LIFE NANOHEALTH project aims to reduce occuptional exposure to process generated nanoparticles (PGNPs) from critical permanently releasing industrial processes by optimizing the performance of Risk Management Measures (RMMs) in indoor exposure scenarios.

The main objective is to reduce the PGNPs occupational exposure associated with high energy industrial processes, optimising the efficiency of the risk management measures in the indoor exposure scenarios.

To achieve it, the following objectives and specific actions are stablished:

Legislative Framework:

Updating the PGNPs available information

Determination of the levels and risks of the PGNPs generated during several industrial processes selected to evaluate the appropriateness of the current framework of nano-reference values for PGNPs.

Tools to evaluating the risks:

Improving the accuracy of the models to simulate the spreading of PGNPs in the indoor air under real operating conditions.

Improving the PGNPs emission data (at least in 10 widely employed industrial processes) and the efficiency of risk management measures with the main aim of reflecting reality in industrial environments under real operating conditions. These data will feed the NANOHEALTH TOOL emission database and will be available for the scientific community.

Identification of the critical points of the PGNPs emissions in industrial environments and the simulation of PGNPs dispersion in industrial plants (at least in 7 facilities). Selection of the most suitable risk management measures and the quantification of the reductions achieved in the assessment of occupational exposure (>75%). An easy to use support tool for making decisions will be developed (NANOHEALTH) for the security and health departments, engineering teams and any other industrial agents interested. This tool based on the industrial process data (covering a minimum of 10 different processes) will be validated though the selected processes, replicated in other industries from the ceramic industry and transferred to other 5 industrial sectors (metallurgical industry, metal-mechanic industry, plastic industry, printing and boat maintenance in shipyards).

Designing of control guidelines and recommendations for the security and health departments and engineering teams to evaluate the PGNPs occupational exposure in industrial processes. In Spain more than 4.100 facilities and 63.000 working people will be potentially benefited by the reduction of the PGNPs risk exposition though NANOHEALTH.

Risk management measures:

Developing an engineering control measure based on the creation of microenvironments with very reduced PGNPs contents. Thus, a highly efficient prototype able to eliminate PGNPs and versatile enough to be implemented in industrial environments: PURIFICADOR NANOHEALTH. This prototype will be tested though 3 industrial processes. The expected efficiency in the microenvironment is of 90%.

Developing of specific trainings in the risks of nanoparticles exposition and its preventive measures.

El proyecto LIFE NANOHEALTH está financiado por el Programa LIFE de la Unión Europea con referencia LIFE20 ENV/ES/000187

Contacte con Nosotros

Subscríbase a

Manténgase actualizado con nuestras últimas noticias. ¡Prometemos no hacer spam!